Navigation Links
VMware Desktop Virtualization Helps Healthcare Providers Improve Patient Care
Date:2/6/2008

ity Act (HIPAA) mandates the security and privacy of health data.

Kindred Healthcare increases caregiver mobility with VMware

Kindred Healthcare is the largest post-acute healthcare provider in the U.S. with approximately 230 nursing centers, more than 80 long-term acute care hospitals and more than 35,000 licensed beds. Kindred needed a better way for its nursing and physician staff to easily access patient data while complying with HIPAA requirements. Kindred deployed VMware virtual desktops on wireless thin clients, mounted on rolling carts. This has enabled caregivers to enter and access medical information securely at the bedside, while letting IT centrally manage patches and upgrades, control access to sensitive data, reduce hardware costs, and provide better patient support.

"Our medical staff needs the flexibility to move around the point of care, without being hampered by cumbersome PCs," said Rob Rhodes, technical consultant at Kindred Healthcare. "Our 'Workstation on Wheels' solution, using VMware virtual desktops on thin clients, can run on a single charge all day long, giving doctors, nurses and clinicians unfettered bedside mobility without interrupting access to patient data and care information."

Huntsville Hospital meets compliance demands with VMware

Huntsville Hospital, a not-for-profit hospital in Huntsville, Alabama with more than 900 licensed beds, has a similar challenge. As a quickly growing organization in a highly regulated industry, Huntsville was looking for a way to enhance the manageability and compliance of its desktop computing infrastructure, while engaging more seamlessly with the community of referring doctors in the surrounding region.

The hospital needed to roll out a new, powerful medical information application throughout its network, while protecting HIPAA-related data.

Deploying hosted desktops on VMware, the hospital was able to increase their desktop deployment agility, lock
'/>"/>

SOURCE VMware
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Kelloggs Frosted Flakes Gold(TM) Helps Moms Get the Gold
2. New strategy helps reduce errors in obstetrical care
3. Sex & the City Gets Serious About HIV and AIDS in South Africa - Kristin Davis Helps Oxfam Break the Stigma and Close the Treatment Gaps Fuelling AIDS
4. Arizona-Based Healthy Lifestyle Corporate Events Helps Football Fans Commit to Good Health
5. High-Dose Chemo Helps Beat Rare Brain Cancer
6. Anti-Clotting Drug Helps Infants With Heart Ills
7. In silico modeling helps predict severity of mitochondrial disease
8. Surprise in Lab Helps ID Drug to Fight ALS
9. Putting on Pedometer Helps Walkers Shed Pounds
10. Hormone Therapy Only Helps Some Older Men With Prostate Cancer
11. Saline Nasal Wash Helps Kids Fight Colds, Flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... Sickle cell disease, a condition characterized ... one of the most common genetic blood disorders ... more than 70,000 Americans.(1) Research presented today at ... of Hematology highlights intriguing studies on the acute ... with this blood disorder, evaluations of both new ...
(Date:12/6/2009)... ON. Dec. 6, 2009 A new study provides ... known as venous thromboembolism (VTE). , The condition ... every year, and occurs when an abnormal clot forms ... causing pain and swelling. In some cases, the clot ... through the heart to the lungs, causing a potentially ...
(Date:12/6/2009)... with the Greater VA Healthcare System in West Los Angeles, will ... to soar to more than 5,000 veterans, active military personnel and ... ... 2009 -- Volunteer organizations and members of the community, in cooperation ... once again create a holiday party. This year,s attendance is expected ...
(Date:12/5/2009)... has shown in a phase 1/2 clinical trial ... treatment of patients newly diagnosed with multiple myeloma, a ... researchers from Dana-Farber Cancer Institute. , Partial responses or ... treated with the drug combination in the multi-center study, ... rate" in the phase 2 population, reports Paul G. ...
(Date:12/5/2009)... ,, What: Cuts for a Cause ... the fight against cancer and other terminal illnesses affecting children. ... to St. Jude Children,s Research Hospital. Guests will enjoy complimentary ... and savory Vietnamese restaurant in Falls Church for all guests. ...
Breaking Medicine News(10 mins):Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2
... Dec. 8 Warner Chilcott Limited (Nasdaq: WCRX ... Hospira, Inc. ("Hospira") have received Paragraph IV Certification Notices from ... advising that each such company has filed an Abbreviated New ... 75 mg delayed-release tablets. , , ...
... abnormalities better regulated when following this approach , , MONDAY, ... risk for heart disease, a Mediterranean diet plus daily ... according to a Spanish study. , Metabolic syndrome ... obesity, high cholesterol, high blood pressure and high glucose ...
... drugs, study finds , , MONDAY, Dec. 8 (HealthDay News) -- ... the least expensive can save millions a year, a new ... that they don,t know which drugs are preferred or not ... medicine at Harvard Medical School and lead author of a ...
... enhancing" drugs is increasing at an alarming rate yet a superior, ... ... (Vocus) December 8, 2008 -- Purported "brain enhancement" drugs such as ... in the United States during the past decade according to the ...
... DATATRAK International, Inc.,(Nasdaq: DATA ), a ... for the clinical trials industry, today announced that ... (the "Staff") of The NASDAQ Stock,Market ("NASDAQ"), dated ... not,demonstrated compliance with the minimum $2.5 million stockholders, ...
... Hair Loss & Replacement for Dummies is an authoritative guide ... to treat it. , , ... M. Bernstein, M.D., F.A.A.D., and Dr. William Rassman, have co-authored ... and women understand hair loss, its prevention, and their medical ...
Other Medicine News:Health News:Warner Chilcott Announces Receipt of Paragraph IV Certification Notices 2Health News:Warner Chilcott Announces Receipt of Paragraph IV Certification Notices 3Health News:Mediterranean Diet Enriched With Nuts Cuts Heart Risks 2Health News:Electronic Prescribing Saves Patients Money 2Health News:Electronic Prescribing Saves Patients Money 3Health News:Brain Boosting Drugs vs. Walking: Treadmill Desk Manufacturer Promotes Common Sense 2Health News:Brain Boosting Drugs vs. Walking: Treadmill Desk Manufacturer Promotes Common Sense 3Health News:DATATRAK International, Inc. Receives Notice from NASDAQ 2Health News:DATATRAK International, Inc. Receives Notice from NASDAQ 3Health News:Hair Transplant Surgeons Author Hair Loss for Dummies Book 2Health News:Hair Transplant Surgeons Author Hair Loss for Dummies Book 3
(Date:12/4/2009)... Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: ... testing of a novel integrated light source architecture for ... design raises the bar on imaging speed and overcomes ... light sources. This approach to optical engines builds ...
(Date:12/4/2009)... Watson Pharmaceuticals, Inc. (NYSE: WPI ), ... its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New ... Administration seeking approval to market its 8mg ramelteon tablets ... Takeda Pharmaceutical Company Limited. Watson,s 8mg ramelteon tablet ...
(Date:12/4/2009)... Neal Shore and E. David Crawford presented results for ... secondary end points of biochemical recurrence rate in a ... injection) or monthly leuprolide in prostate cancer patients during ... who received FIRMAGON 240/80 mg/month had a recurrence rate ...
Breaking Medicine Technology:Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 1Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 2Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 3Amended Chairmans Mark Sets Stage for 26quot 3BHitting Bulls eye in Health Reform 26quot 3B 59224 1Amended Chairmans Mark Sets Stage for 26quot 3BHitting Bulls eye in Health Reform 26quot 3B 59224 2Rest Assured With Clinically Tested Anti Snore Pillow 59219 1Rest Assured With Clinically Tested Anti Snore Pillow 59219 2
... Abeome Corporation, a,Georgia-based biotech company, announced today ... a collaboration with Cato Research Ltd.,its global ... collaboration will help support continued development of ... technology vastly improves the development of,monoclonal antibodies ...
... as the Clinical Gold Standard ... from Decision Resources, WALTHAM, Mass., July 15 ... and advisory firms focusing on pharmaceutical and,healthcare issues, ... of depressive mood episodes in patients who suffer ...
Other Medicine Technology:Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic 2Current and Emerging Drugs Continue to Struggle for Patient Share in the Treatment of Major Depressive Disorder 2
Soft Guedel Oral Airways...
All oral and nasal airways are manufactured with smooth, rounded edges for increased patient comfort and safety., ,Portex® offers a broad selection of airways for a variety of clinical applicati...
... Rapid intubation of difficult airways., ,When ... and accuracy are critical. Now you can ... ventilation with the Combitube®: Esophageal/Tracheal double-Lumen Airway ... Combitube airway is designed to establish a ...
Flexible vinyl with a rigid bite block. Guedel-style with three internal channels. Individually packaged, 48 per case. Latex Free....
Medicine Products: